Manipal Health Enterprises is set to launch its Mainboard IPO on July 29, 2026, targeting approximately ₹9,273.64 crores. The offering will close on July 31, 2026, with shares priced between ₹560 and ₹590.
The company, a significant healthcare provider under the Manipal Group, operates extensively across India.
Operational Scale
- Hospitals (as of Sep 30, 2025): 38 (48 pro forma)
- Licensed Beds (as of Sep 30, 2025): 10,761 (12,367 pro forma)
- Clinics: 17
Manipal Health Enterprises offers a range of medical services, including organ transplants, oncology, and cardiology, focusing on patient care and accessibility.
Grey Market Activity
The Grey Market Premium (GMP) for Manipal Hospitals IPO has shown volatility.
- GMP high (July 20, 2026): ₹50
- GMP (August 5, 2026): ₹3
- Expected Return (based on August 5, 2026 GMP): 0.51%
Investors are advised to evaluate the company’s fundamentals rather than solely relying on fluctuating premium prices, as these can change rapidly.
Key Dates Ahead
The IPO timeline is set with specific dates for allotment and listing.
- IPO Open Date: July 29, 2026
- IPO Close Date: July 31, 2026
- Basis of Allotment: August 3, 2026
- Refunds: August 4, 2026
- Credit to Demat Account: August 4, 2026
- IPO Listing Date: August 5, 2026
The listing on August 5, 2026, will mark Manipal Health Enterprises’ entry into the public market, concluding the significant offering.